Results

Total Results: 446 records

Showing results for "drug".

221. Section 5, Table 3 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-5-table-3.pdf
     August 01, 2014 - , blood culture should be obtained immediately prior to the next scheduled dose to minimize blood drug

222. Improving service systems for youth with serious emotional disorders and their families | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/finalsummary/finalsummary4.html
     September 01, 2015 - and identify service gaps, opportunities for better care coordination, and incidences of psychotropic drug

223. Reducing Harms from Unsafe Use of Antibiotics and Preventing the Spread of Antibiotic Resistance | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/funding/grantee-profiles/grtprofile-trautner.html
     October 01, 2023 - prescription antibiotics without a prescription increases the risk of antibiotic resistance, adverse drug

224. Advancing Academic and Practical Knowledge To Prevent Infections From Hospital to Home | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/funding/grantee-profiles/grtprofile-huang.html
     December 01, 2023 - prevented two infection-related transfers to the hospital each month and cut the overall amount of multi-drug

225. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
     February 02, 2012 - and Statistical Manual for Primary Care CDC—Centers for Disease Control and Prevention FDA—Food and Drug … school–aged children (6–11 years of age), the primary care clinician should prescribe US Food and Drug … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associated with attention-deficit hy­ peractivity disorder (ADHD) drug treatment: a retrospective … Drug Saf. 2009;32(11): 1089–1110 56. Gould MS, Walsh BT, Munfakh JL, et al.

226. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
     February 02, 2012 - and Statistical Manual for Primary Care CDC—Centers for Disease Control and Prevention FDA—Food and Drug … elementary school–aged children (6–11 years of age), the primary care clinician should prescribe US Food and Drug … Silver Spring, MD: Food and Drug Administration, Center for Drug Evaluation and Research; 2004. … Mortality associatedwith attention-deficit hy- peractivity disorder (ADHD) drug treatment: a retrospective … Drug Saf. 2009;32(11): 1089–1110 56. Gould MS, Walsh BT, Munfakh JL, et al.

227. Multiple Settings | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/patient-safety/settings/multiple/index.html
     August 01, 2023 - cahps/surveys-guidance/echo Specialized Surveys: Cancer care—inpatient and outpatient treatment for drug

228. FileNewTemplate
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/teamstepps/officebasedcare/ts-obc-online-module1.pptx
     March 01, 2010 - Reduced rate of adverse drug events Improved medication reconciliation at patient admission Haig, K. … which measures the average severity of each delivery with an adverse event; reduced rate of adverse drug

229. Section 8-A, EHR Data Feasibility Tool (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-199-section-8-a-ehr-data-feasibility-tool.pdf
     November 20, 2017 - shock Unstable shock: The addition of or an increase in a continuous infusion of any cardioactive drug … Any patient that had received and had an increase in a continuous infusion of any cardioactive drug

230. 2013 Annual Hospital-Acquired Condition Rate and Estimates of Cost Savings and Deaths Averted From 2010 to 2013 | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/hai/pfp/hacrate2013.html
     January 01, 2018 - protocol and software tool, to determine whether any of 21 types of adverse events—such as adverse drug … estimates of the deaths averted and cost savings come from declines in pressure ulcers and adverse drug … with an excess mortality rate of 72 deaths per 1,000 and excess costs of $17,000/case, and adverse drug

231. Data Evaluation of All-Payer Claims Databases | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/data/apcd/backgroundrpt/data.html
     April 01, 2017 - multiple encounters that occur on the same day, such as multiple emergency department visits or the same drug … Drug codes for pharmacy claims and details about the prescription, such as whether it is a new prescription … National Drug Code 100% Included in the pharmacy claims, but reliability was not assessed. 7 Prescription

232. Expanding and Enhancing All Payer Claims Database System Capacity in States | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/data/apcd/confrpt.html
     February 01, 2018 - The Food and Drug Administration's (FDA) mini-sentinel network has 17 carrier data partners in a distributed … Association of Insurance Commissioners Kathleen Uhl , Deputy Director, Office of Medical Policy, Center for Drug … Evaluation and Research, Food and Drug Administration This session will highlight new federal and

233. Publications From the Comparative Health System Performance Initiative | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/chsp/publications/index.html
     September 01, 2023 - Consequences of the 340b Drug Pricing Program. N Engl J Med. 2018;378(6):539-48. … Desai SM, McWilliams JM. 340b Drug Pricing Program and Hospital Provision of Uncompensated Care. … Racial and Ethnic Disparities in Opioid Access and Urine Drug Screening Among Older Patients With Poor-Prognosis … A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices

234. Funding Opportunities to Address Opioid and Other Substance Use Disorders | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/opioids/funding-opportunities.html
     February 01, 2023 - AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder Epidemic Drug

235. SDOH and Health Systems Research | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/sdoh/health-systems-research.html
     December 01, 2022 - A patient navigation intervention for drug-involved former prison inmates .

236. Resources and Tools To Improve Discharge and Transitions of Care and Reduce Readmissions | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/patient-safety/resources/improve-discharge/index.html
     July 01, 2022 - Safety and Team Communication Through Daily Huddles AHRQ PSNet Primer: Medication Errors and Adverse Drug

237. Identifying Strategies to Improve Medication Safety at Home | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/funding/grantee-profiles/grtprofile-xiao.html
     November 01, 2022 - The preventable harms for these medication errors include adverse drug events (ADEs), unscheduled hospital

238. TeamSTEPPS for Office-Based Care: Introduction | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/teamstepps/officebasedcare/module1/office_intro.html
     February 01, 2016 - Reduced rate of adverse drug events.

239. Maps and Directions | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/cpi/about/directions/index.html
     December 01, 2017 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

240. PS Grantee Report | Agency for Healthcare Research and Quality
     www.innovations.ahrq.gov/research/findings/final-reports/index.html
     June 01, 2023 - Teamwork, Pediatrics Publication Date: May 2021 Gastrointestinal Safety of Antithrombotic Drug